Presentation TCT 2012

Evaluation of Dose Requirements for Prolonged Bivalirudin Administration in Patients with Renal Insufficiency and Suspected Heparin-Induced Thrombocytopenia.

Presenter: James W. Wisler, Jeffrey B. Washam, Richard C. Becker

January 03, 2012

REGISTER for free or LOG IN to view this content

Evaluation of Dose Requirements for Prolonged Bivalirudin Administration in Patients with Renal Insufficiency and Suspected Heparin-Induced Thrombocytopenia.

CAD Pharma

ACS/AMI

Presentation

TCT 2012

Up Next

Presentation TCT 2012

DES vs. MIDCAB for Proximal LAD disease: Long Term Registry Results

Presenter: Piotr P. Buszman

January 03, 2012

More slides +

Presentation TCT 2012

First Report of A Novel Polymer-Free Dual-Drug Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man BICARE Trial

Presenter: Mengyue Yu

January 03, 2012

Presentation TCT 2012

Differences in cardiovascular risk factors and clinical outcomes between West-European and Southeast Asian patients treated with the EPC capturing stent: A sub-study of the...

Presenter: Margo Klomp

January 03, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.